Biolidics Limited reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was SGD 0.685 million compared to SGD 0.639 million a year ago. Net loss was SGD 2.29 million compared to SGD 3 million a year ago. Basic loss per share from continuing operations was SGD 0.0086 compared to SGD 0.0114 a year ago. Diluted loss per share from continuing operations was SGD 0.0086.